Found: 11
Select item for more details and to access through your institution.
Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 418, doi. 10.1016/j.cllc.2014.06.007
- By:
- Publication type:
- Article
Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 3, p. 188, doi. 10.1016/j.cllc.2013.12.005
- By:
- Publication type:
- Article
Perspectives for Cancer Care and Research in Central and Eastern Europe.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 3, p. 80, doi. 10.1159/000528487
- By:
- Publication type:
- Article
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability.
- Published in:
- BMC Proceedings, 2024, v. 18, n. 2, p. 1, doi. 10.1186/s12919-023-00287-6
- By:
- Publication type:
- Article
Reply to the Correspondence by Untch et al. "Concerning Dediu M, Zielinski C: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer" [Breast Care 2019; DOI 10.1159/000500624].
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer.
- Published in:
- Breast Care, 2020, v. 15, n. 1, p. 67, doi. 10.1159/000500620
- By:
- Publication type:
- Article
Current status and further perspectives in the treatment of EGFR mutant non-small cell lung cancer (NSCLC).
- Published in:
- Oncolog-Hematolog, 2017, n. 39, p. 30
- By:
- Publication type:
- Article
The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer results of a prospective observational study.
- Published in:
- Oncolog-Hematolog, 2017, n. 39, p. 29
- By:
- Publication type:
- Article
The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung.
- Published in:
- Current Oncology, 2023, v. 30, n. 8, p. 7218, doi. 10.3390/curroncol30080523
- By:
- Publication type:
- Article
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT).
- Published in:
- Current Oncology, 2022, v. 29, n. 8, p. 5833, doi. 10.3390/curroncol29080460
- By:
- Publication type:
- Article